Chartwell Investment Partners, LLC Myriad Genetics Inc Transaction History

Chartwell Investment Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 29, 2019	SELL	$22.08 - $47.08 $791,921 - $1.69 Million	-35,866 Closed	0 $0
Q2 2019 Aug 19, 2019	SELL	$22.67 - $35.0 $80,025 - $123,550	-3,530 Reduced 8.96%	35,866 $996,000
Q1 2019 Apr 11, 2019	SELL	$26.93 - $34.7 $18,070 - $23,283	-671 Reduced 1.67%	39,396 $1.31 Million
Q4 2018 Feb 01, 2019	BUY	$27.23 - $45.56 $7,515 - $12,574	276 Added 0.69%	40,067 $1.17 Million
Q3 2018 Nov 08, 2018	SELL	$37.57 - $50.34 $139,948 - $187,516	-3,725 Reduced 8.56%	39,791 $1.83 Million
Q2 2018 Aug 09, 2018	SELL	$27.75 - $40.17 $2.14 Million - $3.09 Million	-77,030 Reduced 63.9%	43,516 $1.63 Million
Q1 2018 May 08, 2018	BUY	$28.83 - $41.01 $2.19 Million - $3.12 Million	76,005 Added 170.64%	120,546 $4.14 Million
Q1 2018 May 08, 2018	SELL	$28.83 - $41.01 $2.19 Million - $3.12 Million	-76,005 Reduced 63.05%	44,541 $1.32 Million
Q4 2017 Feb 08, 2018	BUY	$28.45 - $37.14 $820,241 - $1.07 Million	28,831 Added 31.44%	120,546 $4.14 Million
Q3 2017 Nov 08, 2017	BUY	$24.01 - $36.2 $2.2 Million - $3.32 Million	91,715	91,715 $3.32 Million

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.